← Screener

CORCencora

Health care · Drug Wholesale · NYSE

Compare with peers → Embed

Filings with the SEC since Nov 20, 2018

1,011 filings, 11 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Nov 25, 2025

10-K, period to Sep 30, 2025

Latest quarterly reportOpen ↗

Aug 5, 2026

10-Q, period to Jun 30, 2026

Latest current reportOpen ↗

Nov 4, 2026

8-K: Regulation FD disclosure

Filed in the last 30 days

of 1,011 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 54 events

Nov 4, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Nov 4, 20268-K Regulation FD disclosure 8-K item 7.01
Oct 21, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Sep 25, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Aug 14, 20268-K Director or officer change 8-K item 5.02
Aug 12, 20268-K Regulation FD disclosure 8-K item 7.01
Aug 5, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Aug 5, 20268-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Aug 5, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jun 24, 2026Buy Tyler Lauren M (Director) bought $149K open-market purchase on Jun 22, 2026
Jun 22, 2026Buy DURCAN DERMOT MARK (Director) bought $1.1M open-market purchase on Jun 18, 2026
Jun 15, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
May 29, 2026Officer CFO change Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”).
May 28, 2026Buy DURCAN DERMOT MARK (Director) bought $1.1M open-market purchase on May 28, 2026
May 6, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
May 6, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Mar 23, 20268-K Regulation FD disclosure 8-K item 7.01
Mar 17, 2026Officer CFO change Cleary will retire as Executive Vice President and Chief Financial Officer of the Company effective June 30, 2026.
Mar 6, 20268-K Shareholder vote results 8-K item 5.07
Feb 18, 20268-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
Feb 13, 20268-K Material agreement signed, New debt or obligation, Regulation FD disclosure, Other events 8-K items 1.01, 2.03, 7.01, 8.01
Feb 11, 20268-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
Feb 10, 20268-K Other events 8-K item 8.01
Feb 4, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Feb 4, 202610-Q Quarterly report (10-Q) period ended Dec 31, 2025
Jan 22, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Jan 16, 20268-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Dec 15, 20258-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
Nov 25, 202510-K Annual report (10-K) period ended Sep 30, 2025
Nov 5, 20258-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Sep 9, 20258-K Material agreement signed 8-K item 1.01
Sep 3, 20258-K Other events 8-K item 8.01
Aug 27, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Aug 6, 20258-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Aug 6, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 3, 20258-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Jun 6, 20258-K Material agreement signed, Material agreement ended, New debt or obligation 8-K items 1.01, 1.02, 2.03
May 28, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
May 22, 20258-K Material agreement signed, New debt or obligation, Other events 8-K items 1.01, 2.03, 8.01
May 19, 20258-K Other events 8-K item 8.01
May 7, 20258-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
May 7, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Mar 10, 20258-K Regulation FD disclosure 8-K item 7.01
Mar 10, 20258-K Shareholder vote results 8-K item 5.07
Feb 10, 20258-K Material agreement signed, Other events 8-K items 1.01, 8.01
Feb 5, 20258-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Feb 5, 202510-Q Quarterly report (10-Q) period ended Dec 31, 2024
Jan 22, 20258-K Director or officer change 8-K item 5.02
Jan 2, 20258-K Acquisition or sale of assets completed, Regulation FD disclosure 8-K items 2.01, 7.01
Dec 10, 20248-K Material agreement signed, New debt or obligation, Regulation FD disclosure, Other events 8-K items 1.01, 2.03, 7.01, 8.01
Dec 4, 20248-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
Nov 27, 20248-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Nov 26, 2024Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · We, from time to time, may offer and sell, in one or more offerings, shares of our common stock, shares of our preferred stock, debt securities, depositary shares, warrants, purchase contracts and units.
Nov 26, 202410-K Annual report (10-K) period ended Sep 30, 2024

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1011 Annual & quarterly 32 Current reports (8-K) 144 Insiders 711 Proxy & votes 22 Big owners (13D/13G) 35 Shares & debt offered 22 SEC letters 16 Other 29

Filed	Form	What it is	Period
Jan 22, 2026	DEF 14A	Proxy statement	Mar 5, 2026	all files
Jan 22, 2026	DEFA14A	Extra proxy material		all files
Jan 23, 2025	DEFA14A	Extra proxy material		all files
Jan 23, 2025	DEF 14A	Proxy statement	Mar 6, 2025	all files
Jan 29, 2024	DEFA14A	Extra proxy material		all files
Jan 29, 2024	DEF 14A	Proxy statement	Mar 12, 2024	all files
Jan 17, 2024	PRE 14A		Mar 12, 2024	all files
Jan 27, 2023	DEFA14A	Extra proxy material		all files
Jan 27, 2023	DEF 14A	Proxy statement	Mar 9, 2023	all files
Jan 27, 2022	DEFA14A	Extra proxy material		all files
Jan 27, 2022	DEF 14A	Proxy statement	Mar 10, 2022	all files
Mar 4, 2021	DEFA14A	Extra proxy material		all files
Mar 3, 2021	DEFA14A	Extra proxy material		all files
Mar 2, 2021	DEFA14A	Extra proxy material		all files
Feb 8, 2021	PX14A6G	Shareholder's proxy letter		all files
Jan 28, 2021	DEFA14A	Extra proxy material		all files
Jan 28, 2021	DEF 14A	Proxy statement	Mar 11, 2021	all files
Feb 5, 2020	PX14A6G	Shareholder's proxy letter		all files
Jan 24, 2020	DEFA14A	Extra proxy material		all files
Jan 24, 2020	DEF 14A	Proxy statement	Mar 5, 2020	all files
Jan 18, 2019	DEFA14A	Extra proxy material		all files
Jan 18, 2019	DEF 14A	Proxy statement	Feb 28, 2019	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →